# FDA Inspection 1182133 - Apnar Pharma LLP - September 01, 2022

Source: https://www.keypedia.com/records/fda_inspections/apnar-pharma-llp/27e47ea3-584d-44cd-815b-8076abee3116
Source feed: FDA_Inspections

> FDA Inspection 1182133 for Apnar Pharma LLP on September 01, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1182133
- Company Name: Apnar Pharma LLP
- Inspection Date: 2022-09-01
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 932607 - 2015-07-10](https://www.keypedia.com/records/fda_inspections/apnar-pharma-llp/19815bfe-8bf5-406d-903c-55ffc5fbda97)

Company: https://www.keypedia.com/companies/apnar-pharma-llp/97e27879-d20b-4281-b876-7dbab65dc29d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c